TEI Biosciences, a subsidiary of Integra Life Sciences, specializes in advanced surgical solutions, particularly in the field of hernia repair. Their flagship product, SurgiMend®, is a biologic acellular dermal matrix (ADM) designed to provide effective support for complex hernia repairs. SurgiMend® has demonstrated a low recurrence rate and offers significant advantages over other ADMs, particularly in terms of surgical technique and patient selection. The product's clinical efficacy is supported by a robust body of research, showcasing its long-term outcomes and effectiveness in abdominal wall reconstruction.

In addition to SurgiMend®, TEI Biosciences offers a range of products tailored for plastic and reconstructive surgery. Their portfolio includes various configurations of SurgiMend, such as SurgiMend MP and SurgiMend PRS, which cater to different surgical needs. The company emphasizes the importance of clinical data, providing resources that detail published studies and outcomes related to their products. This commitment to evidence-based practice underscores TEI Biosciences' dedication to improving surgical results and patient care in the realm of hernia repair and reconstructive surgery.

United States

SurgiMend for complex hernia repairs and plastic & reconstructive surgery provides an acellular dermal matrix for soft tissue regeneration applications. The matrix is derived from fetal bovine dermis for long lasting results.

TEI Biosciences (Integra Life Sciences)

Company Details